Attention Deficit Hyperactivity Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Attention Deficit Hyperactivity Disorder stocks.

Attention Deficit Hyperactivity Disorder Stocks Recent News

Date Stock Title
Jul 1 LLY Lilly in deal with Radionetics Oncology on radiopharmaceuticals development
Jul 1 LLY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Jul 1 LLY Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Jul 1 LLY Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Jul 1 LLY Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Jul 1 LLY Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
Jul 1 LLY Atossa Therapeutics updates protocol for breast cancer treatment trial
Jul 1 LLY 10 clinical trials to watch in the second half of 2024
Jul 1 LLY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 30 LLY 5 Reasons Eli Lilly Just Keeps Rising
Jun 30 LLY 2 Top Healthcare Stocks to Buy in June
Jun 30 LLY 3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
Jun 29 LLY The Top Country With Most Scientists per Capita in the World
Jun 29 LLY This Is Massive News for Eli Lilly Investors
Jun 29 LLY Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Jun 28 LLY Eli Lilly and Company (LLY): A Good Growth Stock To Buy Now According to Billionaire Ray Dalio
Jun 28 LLY How Medicare drug price negotiations could hit pharma stocks
Jun 28 LLY HIMS Stock Tumbles: Here's Why It's a Buy Right Now
Jun 28 NLSP NLS Pharmaceutics looks to raise $0.79M via securities offering
Jun 28 CING Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds
Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type. It is characterized by difficulty paying attention, excessive activity, or difficulty controlling behavior which is not appropriate for a person's age. The symptoms appear before a person is twelve years old, are present for more than six months, and may cause problems in at least two settings (such as school, home, or recreational activities). In children, problems paying attention may result in poor school performance. Additionally there is an association with other mental disorders and substance misuse. Although it causes impairment, particularly in modern society, many people with ADHD can have sustained attention span for tasks they find interesting or rewarding (known as hyperfocus).Despite being the most commonly studied and diagnosed mental disorder in children and adolescents, the exact cause is unknown in the majority of cases. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. As of 2015 it is estimated to affect about 51.1 million people globally. Rates are similar between countries and depend mostly on how it is diagnosed. ADHD is diagnosed approximately two times more often in boys than in girls, although the disorder is often overlooked in girls because their symptoms differ from those of boys. About 30–50% of people diagnosed in childhood continue to have symptoms into adulthood and between 2–5% of adults have the condition. In adults inner restlessness rather than hyperactivity may occur. The condition can be difficult to tell apart from other conditions, as well as to distinguish from high levels of activity that are still within the range of normative behaviors.ADHD management recommendations vary by country and usually involve some combination of counseling, lifestyle changes, and medications. The British guideline only recommends medications as a first-line treatment in children who have severe symptoms and for medication to be considered in those with moderate symptoms who either refuse or fail to improve with counseling, though for adults medications are a first-line treatment. Canadian and American guidelines recommend that medications and behavioral therapy be used together as a first-line therapy, except in preschool-aged children. Stimulant medication therapy is not recommended as a first-line therapy in preschool-aged children in either guideline. Treatment with stimulants is effective for at least 14 months; however, their long term effectiveness is unclear. Adults often develop coping skills which make up for some or all of their impairments.The medical literature has described symptoms similar to those of ADHD since the 18th century. ADHD, its diagnosis, and its treatment have been considered controversial since the 1970s. The controversies have involved clinicians, teachers, policymakers, parents, and the media. Topics include ADHD's causes and the use of stimulant medications in its treatment. Most healthcare providers accept ADHD as a genuine disorder in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated. The condition was officially known as attention-deficit disorder (ADD) from 1980 to 1987, while before this it was known as hyperkinetic reaction of childhood.

Browse All Tags